Diagnosis and treatment of thrombosis in children: General principles

Pediatric Blood and Cancer

Volumn 46, Issue 5, 2006, Pages 540-546

  Young, Guy ^a,b  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

Anticoagulation; Thrombosis

Indexed keywords

ALTEPLASE; ANTIVITAMIN K; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANGIOGRAPHY; ARTERY CATHETERIZATION; ARTERY THROMBOSIS; BLEEDING; BRAIN HEMORRHAGE; CHILD; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTERVENTIONAL RADIOLOGY; INTRAVENOUS CATHETER; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PHLEBOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; VALIDATION PROCESS; VASCULAR ACCESS; VEIN THROMBOSIS;

CHILD; HUMANS; THROMBOSIS;

EID: 33645327671     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20626     Document Type: Review

References (18)

1. Hoppe C, Matsunaga A. Pediatric thrombosis. Pediatr Clin North Am 2002;49:1257-1283.
2. Nowak-Gottl U, Kosch A, Schlegel N. Thromboembolism in newborns, infants and children. Thromb Haemost 2001;86:464-474.
3. Richardson MW, Allen GA, Monahan PE. Thrombosis in children: Current perspective and distinct challenges. Thromb Haemost 2002;88:900-911.
4. Monagle P, Chan A, Massicotte P, et al. Antithrombotic therapy in children: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:645S-687S.
5. Kuhle S, Koloshuk B, Marzinotto V, et al. A cross-sectional study evaluating post-thrombotic syndrome in children. Thromb Res 2003;111:227-233.
6. van Ommen CH, Heyboer H, Groothoff JW, et al. Persistent tachypnea in children: Keep pulmonary embolism in mind. J Pediatr Hematol Oncol 1998;20:570-573.
7. Ota S, Wada H, Nobori T, et al. Diagnosis of deep vein thrombosis by plasma-soluble fibrin or D-dimer. Am J Hematol 2005;79:274-280.
8. Goldenberg NA, Knapp-Clevenger R, Marco-Johnson MJ. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Eng J Med 2004;351:1081-1088.
9. Cofrancesco E, Cortellaro M, Corradi A, et al. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement. Thromb Haemost 1998;79:509-510.
10. Chan AK, Deveber G, Monagle P, et al. Venous thrombosis in children. J Thromb Haemost 2003;1:1443-1455.
11. Greenway A, Massicotte MP, Monagle P. Neonatal thrombosis and its treatment. Blood Rev 2004;18:75-84.
12. Zenz W, Arlt F, Sodia S, et al. Intracerebral hemorrhage during fibrinolytic therapy in children: A review of the last thirty years. Semin Thromb Hemost 1997;23:321-332.
13. Gupta AA, Leaker M, Andrew M, et al. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr 2001;139:682-688.
14. Levy M, Benson LN, Burrows PE, et al. Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 1991;118:467-472.
15. Young G. Current and future antithrombotic agents in children. Expert Rev Cardiovasc Ther 2004;2:523-534.
16. Massicotte P. Julian JA, Gent M, et al. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: The REVIVE trial. Thromb Res 2003;109:85-92.
17. Streif W, Andrew M, Marzinotto V, et al. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood 1999;94:3007-3014.
18. Young G, Tarantino MD, Wohrley J, et al. Pilot dose finding and Pharmacokinetic Study of Bivalirudin in Infants with Thrombosis. J Thromb Haemost 2005;3(Suppl. 1).